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There have been frequent suggestions over the last
few years that a national inpatient drug chart is
needed for the UK NHS. Here we draw on The
Hunting of the Snark,1 Lewis Caroll’s nonsense
poem, described by Caroll as ‘An Agony, in
Eight Fits’, to critique this movement, where
Agony is used ‘in the old sense of a struggle that
involves great anguish, bodily pain or death.’2
In most UK hospitals, medicines are prescribed
on a paper drug chart, a proforma on which
doctors prescribe, pharmacists annotate and
nurses record administration of medicines. The
drug chart was developed in the late 1960s,
and shown to be safer than the previous system
of nurse transcription onto medicine cards.3–6
Some variant of the drug chart has been at the
end of beds in English and Welsh wards ever
since; Scotland and Northern Ireland have a
similar document, the Kardex, usually kept cen-
trally on the ward. The stimulus for the current
movement to create a national chart was the excel-
lent EQUIP study7 of prescribing errors made
by hospital doctors. The study, funded by the
General Medical Council (GMC), the regulator
for the medical profession in the UK, found the
prevalence of prescribing errors in inpatient and
discharge medication orders to be 8.9%, un-
acceptably high. The GMC, in a press release8
which accompanied the launch of the report,
called for a national drug chart to improve safety.
Others have echoed the call.9,10 Here, in eight
Fits, we explore and critique the case supporting
this initiative. The first three Fits summarize the
commonly used arguments for a national chart,
and our critiques of them; the remainder represent
additional arguments against a national chart.
Fit the first: The EQUIP study suggested that
differences between drug charts predispose to
error.7 How strong is this evidence? First, drug
chart design was not actually a major cause of
error.7 In this study, the investigators studied the
causes of error by inviting doctors to come to
interview prepared to talk about a case in which
they had made an error in the past. There were
only two of 85 errors in which interviewees felt
that the variation in drug chart designs was a con-
tributing factor. For three other errors, poorly
designed drug charts were also mentioned, but
good design and standardization are not the
same. Second, the methodology may have biased
the causes of errors reported. We know that pre-
scribers are not aware of most errors that they
make,11,12 and suggest that to understand causa-
tion, people need to be interviewed about their
errors soon after they are made. We previously
interviewed doctors within 96 hours of making a
serious prescribing error which they were not
aware of at the time, and variation in drug charts
never emerged as a cause.11 Finally, if you knew
you had made errors in the past, would you be
tempted to describe one in which you had been
culpable (and may look foolish or ignorant),
or describe one in which the fault could be laid
elsewhere? In our view the methodology might
over-represent errors in which unfamiliarity with
the drug chart was the cause.
Fit the Second: Two studies from Australia
suggest that standardization of drug charts, in
combination with education, reduces error. The
first study,13 oft cited in support of drug chart stan-
dardization, showed that when five hospitals
adopted a standard drug chart, the prevalence of
prescribing error reduced from 24 to 19 errors per
100 medication orders. An Australia-wide pilot of
a national chart then reported a reduction from 41
to 28 errors per 100 medication orders14 – both
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studies reporting the prevalence of error
with the new charts to be higher than in the UK
EQUIP study.7 However, the high baseline rates
were partly due to hospitals having prescribing
systems in which prescribers did not indicate
the times at which doses were to be administered.
Prescribers instead specified only the number of
daily doses which nurses then had to trans-
cribe into specific drug round times, resulting in
an additional source of error. Beyond telling us
that some Australian hospitals appear to have
had a poorly designed drug chart at baseline,
it is not evidence that a national drug chart
will reduce errors in the UK. Most English drug
charts are already more like the re-designed
Australian one, rather than those used at base-
line. In each case, education programmes also
accompanied the introduction of the new chart,
which could also have accounted for the improve-
ment. Others have voiced concerns about the
benefits of the Australian national chart.15 In the
UK,we12 have found an example inwhich one hos-
pital had a higher rate of prescribing errors due to
the lack of a section to specify the maximum
dose or frequency for ‘when required’ medication.
Suchfindings suggest there is aclear case foradvice
on good design and content of drug charts, such
as using the standards recently recommended
by the Academy of Medical Colleges.16 However,
this is not the same as recommending a national
drug chart.
Fit the Third: Closer to home, the evidence from
Wales shows that a national chart is achievable.17
Wales has successfully implemented a national
chart, albeit a country with a population less than
half that of London, and a strong sense of national
identity. However, a key reason for the introduc-
tion of this standard chart was to facilitate training
with aWelsh e-learning package for prescribing, so
that all training material could be based on the
standard drug chart. The effects on prescribing
error have not been measured, nor has there been
a study to establish if it created any new problems
or workarounds. The accompanying education on
prescribing may also account for any perceived
benefits. Perhaps the conclusion is that junior
doctors and new staff should be educated about
local drug charts and how to use them.
Fit the Fourth: The fallacious view that one
chart is sufficient. Even within autonomous insti-
tutions such as NHS hospital trusts there is
rarely ‘one’ drug chart – there are usually vari-
ations on the main chart for different clinical
areas such as short stay units, paediatrics and criti-
cal care, plus other supplementary charts, such as
for sliding scale insulin and heparin infusions.
Drug charts also need to support local practices
such as those required to meet local CQUIN
targets in England.18 Being able to adapt charts
locally increases the scope for design to be respon-
sive to local needs and financial drivers. The
notion of one national chart seeks to oversimplify
a complex system, where one size simply will not
fit all.
Fit the fifth: Few technologies are intuitive;
people need to be educated in how to use them.
A drug chart is a technology, albeit a basic one.
The lack of a standard drug chart could be seen
as the problem, but the problem could equally
be seen as a lack of education in the use of drug
charts. Drug charts vary in detail, but are largely
the same. An analogy is cars, which may be differ-
ent in the location of various controls but are
all basically the same, and anyone with a valid
driving license should be able to drive any car.
Undergraduate medical prescribing education
should be based on a typical drug chart; post-
graduate prescribing education could then focus
on specific charts in use in the relevant hospital.
To focus the blame on a technology can distract
from the importance of education in good pre-
scribing and the appropriate use and understand-
ing of local prescribing stationery. We believe
that instead, NHS organizations should focus on
appropriate induction for medical staff regarding
local prescribing stationery. Medical schools
should use typical examples of hospital drug
charts when teaching prescribing, and medical
students should be encouraged to familiarize
themselves with drug charts during their clinical
placements through involvement in prescribing
audit, structured observation of the prescribing
and administration of medication, and through
mock prescribing assignments.
Fit the sixth: There were 21 recommendations
given in the GMC funded EQUIP report,7 but
the accompanying press release8 focused only
on one of these, the one relating to drug chart
standardization. The other 20 recommendations,
mainly relating to medical staff education and
other aspects of the clinical environment, were
largely ignored.
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Fit the seventh: Electronic prescribing is increas-
inglyprevalent inUKhospitals.Currently it is used
in many hospitals for cancer and discharge medi-
cation systems, but increasingly it will also be
used for all inpatient prescribing. The disparity
between different systems, for example in entry
screens and decision support, is so vast that
current UK prescription charts appear identical in
comparison. Here is a technology that is already
supplanting the current prescription charts, and
can create a new and significant risk of error.19
Presenting and inputting information on a compu-
ter screen is very different from on paper, and in
our view, working on how best to support user
interface design for electronic prescribing is far
more important than the standardization of paper
drug charts, which will soon be defunct.
Fit the eighth: At the start of The Hunting of the
Snark we are told that the Baker had been warned
that you must be careful when hunting a Snark,
for if yours is also a Boojum then you will ‘softly
and suddenly vanish away’. We think a national
drug chart is both Snark and Boojum, and are con-
cerned that the things that will be softly and sud-
denly vanishing away are the quality of life, and
the lives, of patients who are harmed while calls
for a national drug chart take the time and energy
that could be applied to addressing more impor-
tant causes of prescribing error. Instead, other
actions to prevent prescribing errors are needed,
including better induction programmes, feedback
on prescribing errors made, incorporation of safe
prescribing into both undergraduate and post-
graduate education, and judicious introduction
and use of electronic prescribing. The benefits of
these are much less likely to ‘softly and suddenly
vanish away’.
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